-
Have you administered the initial dose of Gardasil, the quadrivalent human papillomavirus (HPV) vaccine, to a young woman with private insurance, only to later discover that her policy does not cover vaccine reimbursement?
-
What can you tell teens about preventing chlamydia? Check the following information from the Centers for Disease Control and Prevention (CDC):
-
When it comes to emergency contraception (EC), what does your clinic offer? A new review has found that mifepristone is the most effective EC method to prevent unwanted pregnancy; however, the drug has not gained U.S. regulatory approval for that use.
-
The woman in your exam room says she has severe headaches that usually begin about two days before her menstrual cycle. When they occur, they get more severe in intensity. She does not report any signs of neurological aura, such as flashing lights or tingling sensations, with the headaches. What's your diagnosis?
-
When it comes to administering the vaccine for human papillomavirus (HPV), providers are following the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices' recommendation to target all girls ages 11-12 for routine vaccination.
-
In this review of patients admitted to the ICU with acute respiratory failure secondary to COPD exacerbation or cardiogenic pulmonary edema, nearly two-thirds of patients who apparently met criteria for noninvasive ventilation (NIV) were intubated without a trial of NIV.
-
Institution of a daily pharmacist-enforced intervention designed to improve adherence to sedation guidelines decreased the duration of mechanical ventilation and ICU stay.
-
Elevated troponin i is a nonspecific finding, but suggests a poor prognosis regardless of its cause.
-
Ceftobiprole, a novel broad-spectrum cephalosporin with activity against MRSA, was non-inferior to vancomycin plus ceftazidime in a study of complicated skin and skin-structure infections. This is the first β-lactam with reliable activity against methicillin resistant Staphylococcus aureus (MRSA) to be evaluated in advanced-stage clinical trials.
-
Randomized studies of neuroprotective agents for ischemic stroke have resulted in a series of failures, as multiple agents, promising in animal models, have failed when applied to human subjects. By contrast, intracerebral hemorrhage (ICH) has been somewhat a "neglected stepsister" when compared to ischemic stroke; it has been studied minimally, despite its high morbidity and mortality.
